Guo Q, Zhai Q, Ji P
Pharmaceuticals (Basel). 2024; 17(10).
PMID: 39458939
PMC: 11510265.
DOI: 10.3390/ph17101297.
Valverde A, George A, Nares S, Naqvi A
J Periodontal Res. 2024; 60(2):101-120.
PMID: 39044454
PMC: 11873684.
DOI: 10.1111/jre.13326.
Vasconcelos J, Souza N, Leite L, Junior J
Rev Bras Ortop (Sao Paulo). 2024; 59(Suppl 1):e119-e122.
PMID: 39027179
PMC: 11254433.
DOI: 10.1055/s-0043-1770906.
Wilcox C, Knych H, Katzman S, Arthur R, Rodriguez V, Finno C
J Vet Pharmacol Ther. 2024; 47(3):187-192.
PMID: 38197553
PMC: 11052667.
DOI: 10.1111/jvp.13424.
Slade L, Bollen S, Bass J, Phillips B, Smith K, Wilkinson D
J Cachexia Sarcopenia Muscle. 2023; 14(6):2613-2622.
PMID: 37722921
PMC: 10751425.
DOI: 10.1002/jcsm.13335.
Leucine Repeat Rich Kinase 1 Controls Osteoclast Activity by Managing Lysosomal Trafficking and Secretion.
Shen S, Si M, Zeng C, Liu E, Chen Y, Vacher J
Biology (Basel). 2023; 12(4).
PMID: 37106712
PMC: 10135754.
DOI: 10.3390/biology12040511.
Local delivery of gaseous signaling molecules for orthopedic disease therapy.
Sun J, Wang W, Hu X, Zhang X, Zhu C, Hu J
J Nanobiotechnology. 2023; 21(1):58.
PMID: 36810201
PMC: 9942085.
DOI: 10.1186/s12951-023-01813-6.
Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database.
Hasegawa S, Ikesue H, Satake R, Inoue M, Yoshida Y, Tanaka M
Drugs Real World Outcomes. 2022; 9(4):659-665.
PMID: 35933498
PMC: 9712889.
DOI: 10.1007/s40801-022-00324-4.
Incomplete Atypical Femoral Fracture Treated by Prophylactic Intramedullary Nail Fixation: A Case Series.
Sakuda T, Omoto O, Hamasaki T, Okimoto N, Adachi N
Cureus. 2022; 14(2):e22725.
PMID: 35386143
PMC: 8968090.
DOI: 10.7759/cureus.22725.
7,8-Dihydroxyflavone modulates bone formation and resorption and ameliorates ovariectomy-induced osteoporosis.
Xue F, Zhao Z, Gu Y, Han J, Ye K, Zhang Y
Elife. 2021; 10.
PMID: 34227467
PMC: 8285109.
DOI: 10.7554/eLife.64872.
COVID-19 and the Endocrine System: A Comprehensive Review on the Theme.
Lisco G, De Tullio A, Stragapede A, Solimando A, Albanese F, Capobianco M
J Clin Med. 2021; 10(13).
PMID: 34209964
PMC: 8269331.
DOI: 10.3390/jcm10132920.
Learning from Monocyte-Macrophage Fusion and Multinucleation: Potential Therapeutic Targets for Osteoporosis and Rheumatoid Arthritis.
Gambari L, Grassi F, Roseti L, Grigolo B, Desando G
Int J Mol Sci. 2020; 21(17).
PMID: 32825443
PMC: 7504439.
DOI: 10.3390/ijms21176001.
Using Pharmacy Data and Adherence to Define Long-Term Bisphosphonate Exposure in Women.
Izano M, Neugebauer R, Ettinger B, Hui R, Chandra M, Adams A
J Manag Care Spec Pharm. 2019; 25(6):719-723.
PMID: 31134854
PMC: 7831658.
DOI: 10.18553/jmcp.2019.25.6.719.
Calcium Phosphates as Delivery Systems for Bisphosphonates.
Bigi A, Boanini E
J Funct Biomater. 2018; 9(1).
PMID: 29342839
PMC: 5872092.
DOI: 10.3390/jfb9010006.
The effect of low-dose intravenous bisphosphonate treatment on osteoporosis in children with quadriplegic cerebral palsy.
Moon S, An Y, Kim S, Kwon Y, Lee J
Korean J Pediatr. 2018; 60(12):403-407.
PMID: 29302265
PMC: 5752641.
DOI: 10.3345/kjp.2017.60.12.403.
Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties.
Ma S, Goh E, Jin A, Bhattacharya R, Boughton O, Patel B
Sci Rep. 2017; 7:43399.
PMID: 28262693
PMC: 5338252.
DOI: 10.1038/srep43399.
Pregnancy-related osteoporosis and spinal fractures.
Yun K, Han S, Kim S, Joo J, Lee K
Obstet Gynecol Sci. 2017; 60(1):133-137.
PMID: 28217686
PMC: 5313358.
DOI: 10.5468/ogs.2017.60.1.133.
Atypical femoral shaft fractures secondary to long-term bisphosphonate therapy.
Kayali C, Altay T, Ozan F, Sozkesen S, Yamak K
J Orthop. 2017; 14(2):226-230.
PMID: 28203048
PMC: 5293726.
DOI: 10.1016/j.jor.2017.01.002.
Subtrochanteric Femoral Insufficiency Fracture in Woman on Bisphosphonate Therapy for Glucocorticoid-Induced Osteoporosis.
Bush L, Chew F
Radiol Case Rep. 2016; 4(1):261.
PMID: 27843524
PMC: 5106554.
DOI: 10.2484/rcr.v4i1.261.
Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women.
Bilek L, Waltman N, Lappe J, Kupzyk K, Mack L, Cullen D
BMC Womens Health. 2016; 16(1):59.
PMID: 27576310
PMC: 5004254.
DOI: 10.1186/s12905-016-0339-x.
